American Journal of Medical Genetics Part C-Seminars in Medical Geneti

Papers
(The median citation count of American Journal of Medical Genetics Part C-Seminars in Medical Geneti is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Bone health in RASopathies84
Correction to “The Rise of the Genetic Counseling Profession in China”68
Beyond chromosome analysis: Additional genetic testing practice in a Down syndrome clinic63
Endocrinological manifestations in RASopathies42
C3 glomerulopathy: Understanding an ultra‐rare complement‐mediated renal disease42
Health care satisfaction and medical literacy habits among caregivers of individuals with Down syndrome32
Catatonia responsive to corticosteroids in a patient with an SCN2A variant31
Unlocking the potential of the UK 100,000 Genomes Project—lessons learned from analysis of the “Congenital Malformations caused by Ciliopathies” cohort30
Newborn screening research sponsored by the NIH: From diagnostic paradigms to precision therapeutics30
Cover Image, Volume 187, Number 4, December 202128
Down syndrome across the lifespan27
Evolution of Health Care in Turner Syndrome27
Table of Contents, Volume 196, Number 4, December 202423
Everyone Is a Tomato: Metagnostic Narratives of Genetic Revelation22
Central nervous system involvement in individuals withRASopathies22
Neurodevelopmental and other psychiatric disorders in 22q11.2 deletion syndrome from childhood to adult age: Prospective longitudinal study of 100 individuals21
Proximal urea cycle defects are challenging to detect with newborn screening: Results of a prospective pilot study using post‐analytical tools20
A Genomic Analysis of Usher Syndrome: Population‐Scale Prevalence and Therapeutic Targets19
Research Review of Myhre Syndrome19
18
Publication schedule for 202318
My Journey With Arthrogryposis and Some of the People Who Made a Difference15
Retrospective review of the code status of individuals with Down syndrome during the COVID‐19 era15
Co‐occurring conditions in Down syndrome: Findings from a clinical database15
Children with Down syndrome who experience developmental skill loss, characterization, and phenomenology: A case series14
14
Genetic testing and glomerular hematuria—A nephrologist's perspective13
Revisiting the Neuropsychological and Clinical Profile of Mosaic Turner Syndrome With a Ring X Chromosome13
Infantile epileptic spasms syndrome in children with cardiofaciocutanous syndrome: Clinical presentation and associations with genotype13
Newborn screening and the recommended uniform screening panel: Optimal submissions and suggested improvements based on an advocacy organization's decade‐long experience13
Cover Image, Volume 190, Number 1, March 202212
Caregivers' concerns and supports needed to care for adults with Down syndrome12
Correction to “Experiences With Offering Pro Bono Medical Genetics Services in the West Indies: Benefits to Patients, Physicians, and the Community”11
Non‐Invasive Prenatal Testing by Cell‐Free DNA ( cfNIPT ) for Detecting Turner Syndrome With Mosai11
Family Lore, a Variant of Uncertain Significance, and CADASIL11
Occurrence of mosaic Down syndrome and prevalence of co‐occurring conditions in Medicaid enrolled adults, 2016–201911
Adult experiences in Beckwith–Wiedemann syndrome11
A plot TWIST9
Duchenne expert physician perspectives on Duchenne newborn screening and early Duchenne care9
In Utero Therapies, the Next Frontier9
Normal joint range of motion in children with Down syndrome9
Table of Contents, Volume 199, Number 1, March 20258
Disease mechanisms of monogenic congenital anomalies of the kidney and urinary tract8
Autism and mild epilepsy associated with a de novo missense pathogenic variant in the GTPase effector domain of DNM18
Cover Image, Volume 196, Number 1, March 20248
Whole‐genome sequencing holds the key to the success of gene‐targeted therapies8
Cover Image, Volume 193, Number 1, March 20237
Cover Image, Volume 190, Number 3, September 20227
Ophthalmologic and neuro‐ophthalmologic findings in children with Down syndrome7
Table of Contents, Volume 190, Number 2, June 20227
Integration of EpiSign, facial phenotyping, and likelihood ratio interpretation of clinical abnormalities in the re‐classification of an ARID1B missense variant6
Monogenic focal segmental glomerulosclerosis: A conceptual framework for identification and management of a heterogeneous disease6
Circles6
Parental Decision‐Making Following a Prenatal Diagnosis of Turner Syndrome: A Systematic Review6
Repurposing With Purpose: Treatment of Bachmann–Bupp Syndrome With Eflornithine and Implications for Other Polyaminopathies6
Publication schedule for 20216
Genesis and genetics of a miracle6
Table of Contents, Volume 193, Number 4, December 20236
Data sharing to advance gene‐targeted therapies in rare diseases6
Table of Contents, Volume 193, Number 1, March 20236
Artificial intelligence and the impact on medical genetics5
Ode to Fiona: The Face of Fortitude in FBXL4 Deficiency5
New prospectives on treatment opportunities in RASopathies5
The National Institutes of Health INvestigation of Co‐occurring conditions across the Lifespan to Understand Down syndromE (INCLU5
Treatment of PDGFRB‐Related Penttinen Syndrome With Imatinib in a Young Child5
COL1A1 and COL1A2 variants in Ehlers‐Danlos syndrome phenotypes and COL1‐related overlap disorder4
Table of Contents, Volume 193, Number 3, September 20234
4
Cover Image, Volume 199, Number 1, March 20254
Autosomal dominant tubulointerstitial kidney disease: A review4
Comment From the Guest Editors4
Systematic assessment of monogenic etiology in adult‐onset kidney stone formers undergoing urological intervention–evidence for genetic pretest probability4
Biallelic variants in CENPF causing a phenotype distinct from Strømme syndrome4
4
Investigations of an individual with a Marfanoid habitus, mild intellectual disability, and severe social anxiety identifies PCDHGA5 as a candidate neurodevelopmental disorder gene3
Invisible strings3
Publication schedule for 20223
The heart in RASopathies3
Publication schedule for 20233
Comments From the Guest Editors3
3
Cover Image, Volume 193, Number 3, September 20233
OFD1: One gene, several disorders3
Introduction to special issue for kidney genetics3
Newborn screening for neurodevelopmental diseases: Are we there yet?2
Cover Image, Volume 190, Number 2, June 20222
Clinical overview on RASopathies2
First a Provider, Now a Patient: Receiving a Devastating Diagnosis Through the Patient Portal2
Application of facial analysis Technology in Clinical Genetics: Considerations for diverse populations2
Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophy2
Natural history of MRAS‐related Noonan syndrome: Evidence of mild adult‐onset left ventricular hypertrophy and neuropsychiatric features2
Family adaptation in families of individuals with Down syndrome from 12 countries2
Applications of artificial intelligence in clinical laboratory genomics2
Pneumonia vaccine response in individuals with Down syndrome at three specialty clinics2
Development of webcam‐collected and artificial‐intelligence‐derived social and cognitive performance measures for neurodevelopmental genetic syndromes2
Role of primary cilia and Hedgehog signaling in craniofacial features of Ellis–van Creveld syndrome2
On stillness2
Spreading the Word: Communicating Evidence‐Based Guidelines About Turner Syndrome to Patients, Parents, Providers, and Payors2
Molecular advances, clinical management, and treatment opportunities in RASopathies2
Mental health in adults living with arthrogryposis multiplex congenita1
Practicalities (and real‐life experiences) of dementia in adults with Down syndrome1
A review of economic issues for gene‐targeted therapies: Value, affordability, and access1
Why must the debate continue on Krabbe disease newborn screening?1
Diagnostic experiences of Duchenne families and their preferences for newborn screening: A mixed‐methods study1
Publication schedule for 20221
Special issue: Newborn screening research1
Note from the editors1
Gene‐targeted therapies: Overview and implications1
Quality of life measures in children with Down syndrome with disorders of gut–brain interaction1
Different, Not Less1
Multiorgan manifestations of COL4A1 and COL4A2 variants and proposal for a clinical management protocol1
Spectrum of white matter abnormalities associated with FOXC1‐related disorders in two unrelated cases1
Publication schedule for 20231
Moving away from one disease at a time: Screening, trial design, and regulatory implications of novel platform technologies1
Psychopharmacological treatments in Down syndrome and autism spectrum disorder: State of the research and practical considerations1
1
Parent Narratives Provide Perspectives on the Experience of Care in Trisomy 181
Turner Syndrome and Psychosocial Interventions: Recommendations for Collaborative Communication Between Medical and School Teams1
Perspectives and Insights Into Phenylketonuria: Patient Narratives About the Early Years Following Newborn Screening1
Healthy transition: Roadmap for young adults with Down syndrome to adulthood1
1
Growth and Growth‐Promoting Treatments in Turner Syndrome1
The Pediatric Integrated Care Survey (PICS) in a multidisciplinary clinic for Down syndrome1
1
1
0.98588395118713